Article
Recent Progress and Future Prospective in HBV Cure by CRISPR/Cas
21 Dec 2021
Abstract excerpt
Hepatitis B virus (HBV) infection remains an important issue of global public health. Although current antiviral therapy has dramatically reduced the mortality and morbidity of chronic hepatitis B (CHB), it fails to cure it. Rebound viremia often occurs after stopping antiviral therapy. Persistent HBV covalently closed circular DNA (cccDNA) and integrated DNA under antiviral therapy form the major barrier to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
